Scholtz & Company’s Healthcare Realty HR Stock Holding History

Scholtz & Company’s Portfolio HR Stock Details HR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-128,420	Closed	-$4.15M	–	35
2016 Q2	$4.15M	Sell	128,420 -1,105	-0.9%	-$33.3K	4.27%	4
2016 Q1	$3.81M	Buy	+129,525	New	+$3.59M	3.81%	11

Other funds holding HR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CIMLRA

CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ACI

AMP Capital Investors Sydney, Australia $2.37B AUM 23.59% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Scholtz & Company's HR Position: Q3 2016 in Review

Scholtz & Company sold out of Healthcare Realty (HR) in Q3 2016, closing a stake of 128,420 shares — an estimated $4.15M sold.

Scholtz & Company first reported a position in HR in Q1 2016 and held it in 2 quarters. The position peaked at $4.15M in Q2 2016. 243 funds tracked by Wall St. Rank hold HR as of Q3 2016.

Scholtz & Company reported no remaining Healthcare Realty position as of Q3 2016 after selling out during the quarter.
Scholtz & Company sold 128,420 Healthcare Realty shares in Q3 2016, an estimated $4.15M.
Scholtz & Company first reported a position in Healthcare Realty in Q1 2016 and held it in 2 quarters.
Scholtz & Company's Healthcare Realty position peaked at $4.15M in Q2 2016.
243 funds tracked by Wall St. Rank held Healthcare Realty as of Q3 2016.

Based on Scholtz & Company's 13F filing for Q3 2016, filed 14 Nov 2016.